AXGN | Axogen inc - Stock Value & PE Ratio Analysis

3

24

15

Limited Growth

AI analysis rates AXGN with a lower value score of 2.
It is mainly due to unstable operating cash flow, along with potential value may be lower.
Over the past 3 months, AXGN has maintained a consecutive value rating of 2.0, slightly lower than the rating of 2.8 over the past 3 years, indicating slight decrease in enterprise value.
Compared to all stocks in the Health Care sector, AXGN has a medium value rating.

AXGN Value Reference Factors

The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.

Update to 2025/02/28 (Weekly Update)

AXGN Financial Forecast

Unit : USD

Update to 2025/5/9 (Quarterly Update)

AXGN Earnings Table

Unit : USD

QTR	Non-GAAP EPS	EPS YoY	EPS Surprise %	Sales	Sales YoY	Sales Surprise %	NPM
Current	0.08	233.3%	100%	49.41M	15.1%	2.3%	-3.8%
2024Q2	0.07	600%	1,066.7%	48.64M	17.9%	2.5%	-4%
2024Q1	0.05	266.7%	-200%	47.91M	25.6%	10.4%	-16%
2023Q4	-0.06	40%	-40%	41.38M	12.9%	-4.6%	-9.1%
2023Q3	-0.06	-100%	-33.3%	42.92M	18.7%	3.1%	-9.9%

Update to 2025/5/10 (Quarterly Update)

AXGN Historical Value Score

You can use historical scores of 3 or above to observe potential performance and make investment decisions.

AXGN Value Strategy Backtest

The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.

Entry

Exit

The Backtest Result of AXGN from 2012/08 till Now

3.09%
Cumulative Return: 0.24%
Annual Return: 33.41%
Volatility: 0.01
Sharpe Ratio

Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from August, 2012 to May, 2025. (Total Trades: 2)